Phototherapy and photochemotherapy of sclerosing skin diseases

Photodermatology Photoimmunology and Photomedicine

Volumn 21, Issue 3, 2005, Pages 157-165

  Brenner, Michaela ^a   Herzinger, Thomas ^a   Berking, Carola ^a   Plewig, Gerd ^a   Degitz, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Photochemotherapy; Phototherapy; PUVA; Sclerosing skin diseases; UVA1

Indexed keywords

METHOXSALEN; PSORALEN;

CLINICAL TRIAL; DNA ADDUCT; DRUG EFFICACY; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; NECROBIOSIS LIPOIDICA; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; RADIATION DOSE; REVIEW; SCLEREDEMA; SCLERODERMA; SCLEROMYXEDEMA; SYSTEMIC SCLEROSIS; ULTRAVIOLET A RADIATION;

HUMANS; PHOTOCHEMOTHERAPY; SCLEROSIS; SKIN; SKIN DISEASES;

EID: 20144379967     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2005.00154.x     Document Type: Review

References (72)

1. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M. Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet 1994; 343: 1233.
2. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
3. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-944.
4. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
5. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003; 148: 626-637.
6. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000; 16: 43-49.
7. Degitz K, Plewig G, Rocken M. Rapid decline in photosensitivity after 8-methoxypsoralen bathwater delivery. Arch Dermatol 1996; 132: 1394-1395.
8. Neumann NJ, Ruzicka T, Lehmann P, Kerscher M. Rapid decrease of phototoxicity after PUVA bath therapy with 8-methoxypsoralen. Arch Dermatol 1996; 132: 1394.
9. Schempp CM, Schopf E, Simon JC. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath. Photodermatol Photoimmunol Photomed 1996; 12: 100-102.
10. Grundmann-Kollmann M, Tegeder I, Ochsendorf FR, et al. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations. Br J Dermatol 2001; 144: 991-995.
11. Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol 2000; 142: 22-31.
12. Hönigsmann H, Szeimies RF, Knobler R, Fitzpatrick TB, Pathak MA, Wolff K. Photochemotherapy and photodynamic therapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine. 5th edn. New York: McGraw-Hill, 1999; 2880-2900.
13. Ibbotson SH, Farr PM. The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999; 113: 346-350.
14. Staberg B, Wulf HC, Klemp P, Poulsen T, Brodthagen H. The carcinogenic effect of UVA irradiation. J Invest Dermatol 1983; 81: 517-519.
15. Setlow RB, Grist E, Thompson K, Woodhead AD. Wave-lengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993; 90: 6666-6670.
16. Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
17. Morison WL, Baughman RD, Day RM, et al. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol 1998; 134: 595-598.
18. Stern RS, Bagheri S, Nichols K. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-39.
19. de Rie MA, Enomoto DN, de Vries HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003; 207: 298-301.
20. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001; 45: 697-699.
21. Kreuter A, Gambichler T, Avermaete A, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol 2001; 18: 241-245.
22. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001; 17: 149-155.
23. Gruss C, Stucker M, Kobyletzki G, Schreiber D, Altmeyer P, Kerscher M. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997; 136: 293-294.
24. Steger JW, Matthews JH. UVA therapy for scleroderma. J Am Acad Dermatol 1999; 40: 787-788.
25. Kerscher M, Meurer M, Sander C, et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996; 132: 1280-1282.
26. Pasic A, Ceovic R, Lipozencic J, et al. Phototherapy in pediatric patients. Pediatr Dermatol 2003; 20: 71-77.
27. Grundmann-Kollmann M, Ochsendorf F, Zollner TM, et al. PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol 2000; 43: 675-678.
28. Garcia-Bustinduy M, Noda A, Sanchez R, Gonzalez de Mesa MJ, Guimera F, Garcia-Montelongo R. PUVA therapy in localized scleroderma. J Eur Acad Dermatol Venereol 1998; 10: 283-284.
29. Morison WL. Psoralen UVA therapy for linear and generalized morphea. J Am Acad Dermatol 1997; 37: 657-659.
30. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol 2002; 138: 99-105.
31. Von Kobyletzki G, Uhle A, Pieck C, Hoffmann K, Altmeyer P. Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol 2000; 136: 275-276.
32. Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000; 43: 670-674.
33. Luftl M, Degitz K, Plewig G, Röcken M. Psoralen bath plus UV-A therapy. Possibilities and limitations. Arch Dermatol 1997; 133: 1597-1603.
34. Kanekura T, Fukumaru S, Matsushita S, Terasaki K, Mizoguchi S, Kanzaki T. Successful treatment of scleroderma with PUVA therapy. J Dermatol 1996; 23: 455-459.
35. Hofer A, Soyer HP. Oral psoralen-UV-A for systemic scleroderma. Arch Dermatol 1999; 135: 603-604.
36. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995; 32: 393-416.
37. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353: 1777-1783.
38. Kreuter A, von Kobyletzki G, Happe M, et al. UVA1-Phototherapie bei Lichen sclerosus et atrophicus. Hautarzt 2001; 52: 878-881.
39. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002; 46: 251-255.
40. Kreuter A, Jansen T, Stucker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26: 30-32.
41. Von Kobyletzki G, Freitag M, Hoffmann K, Altmeyer P, Kerscher M. Balneophotochemotherapy with 8-methoxypsoralen in lichen sclerosis et atrophicus. Hautarzt 1997; 48: 488-491.
42. Reichrath J, Reinhold U, Tilgen W. Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy: an open pilot study in 12 patients. Dermatology 2002; 205: 245-248.
43. Stander H, Schiller M, Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol 2002; 46: 799-800.
44. Calzavara Pinton P, Porta F, Izzi T, et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica 2003; 88: 1169-1175.
45. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlober P, Peter RU, Kerscher M. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000; 42: 134-136.
46. Eppinger T, Ehninger G, Steinert M, Niethammer D, Dopfer R. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease. Transplantation 1990; 50: 807-811.
47. Vogelsang GB, Wolff D, Altomonte V, et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061-1067.
48. Leiter U, Kaskel P, Krahn G, et al. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photodermatol Photoimmunol Photomed 2002; 18: 183-190.
49. Ulmer A, Schaumburg-Lever G, Bauer J, Kotter I, Fierlbeck G. Scleredema adultorum Buschke: case report and review of the literature. Hautarzt 1998; 49: 48-54.
50. Hager CM, Sobhi HA, Hunzelmann N, et al. Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 1998; 38: 240-242.
51. Grundmann-Kollmann M, Ochsendorf F, Zollner TM, Spieth K, Kaufmann R, Podda M. Cream PUVA therapy for scleredema adultorum. Br J Dermatol 2000; 142: 1058-1059.
52. Verbov JL, Borrie PF. Scleromyxoedema - a variant of lichen myxoedematosus (papular mucinosis). Br J Dermatol 1969; 81: 871-873.
53. Farr PM, Ive FA. PUYA treatment of scleromyxoedema. Br J Dermatol 1984; 110: 347-350.
54. Adachi Y, Iba S, Horio T. Successful treatment of lichen myxoedematosus with PUVA photochemotherapy. Photodermatol Photoimmunol Photomed 2000; 16: 229-231.
55. Yamazaki S, Fujisawa T, Yanatori A, Yamakage A. A case of lichen myxedematosus with clearly exacerbated skin eruptions after UVB irradiation. J Dermatol 1995; 22: 590-593.
56. Penmetcha M, Highet AS, Hopkinson JM. Failure of PUVA in lichen myxoedematosus: acceleration of associated multiple keratoacanthomas with development of squamous carcinoma. Clin Exp Dermatol 1987; 12: 220-223.
57. De Rie MA, Sommer A, Hoekzema R, Neumann HA. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002; 147: 743-747.
58. McKenna DB, Cooper EJ, Tidman MJ. Topical psoralen plus ultraviolet A treatment for necrobiosis lipoidica. Br J Dermatol 2000; 143: 1333-1335.
59. Patel GK, Mills CM. A prospective open study of topical psoralen-UV-A therapy for necrobiosis lipoidica. Arch Dermatol 2001; 137: 1658-1660.
60. Godar DE. Light and death: photons and apoptosis. J Invest Dermatol Symp Proc 1999; 4: 17-23.
61. Bernerd F, Asselineau D. UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photo-aging. Cell Death Differ 1998; 5: 792-802.
62. Herrmann G, Wlaschek M, Lange TS, Prenzel K, Goerz G, Scharffetter-Kochanek K. UVA irradiation stimulates the synthesis of various matrix-metalloproteinases (MMPs) in cultured human fibroblasts. Exp Dermatol 1993; 2: 92-97.
63. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-1296.
64. Petersen MJ, Hansen C, Craig S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 1992; 99: 440-444.
65. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
66. Oikarinen A, Karvonen J, Uitto J, Hannuksela M. Connective tissue alterations in skin exposed to natural and therapeutic UV-radiation. Photodermatol 1985; 2: 15-26.
67. Johnston KJ, Oikarinen AI, Lowe NJ, Clark JG, Uitto J. Ultraviolet radiation-induced connective tissue changes in the skin of hairless mice. J Invest Dermatol 1984; 82: 587-590.
68. Sakura S, Fujimoto D, Sakamoto K, Mizuno A, Motegi K. Photolysis of pyridinoline, a cross-linking amino acid of collagen, by ultraviolet light. Can J Biochem 1982; 60: 525-529.
69. Song PS, Tapley KJ Jr. Photochemistry and photobiology of psoralens. Photochem Photobiol 1979; 29: 1177-1197.
70. Joerges C, Kuntze I, Herzingler T. Induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiation. Oncogene 2003; 22: 6119-6128.
71. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-242.
72. Enk CD, Elad S, Vexler A, Kapelushnik J, Gorodetsky R, Kirschbaum M. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant 1998; 22: 1179-1183.